Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

96.10
Delayed Data
As of Oct 20
 -0.38 / -0.39%
Today’s Change
55.06
Today|||52-Week Range
98.26
+53.47%
Year-to-Date

Today’s Trading

Previous close96.48
Today’s open96.78
Day’s range94.89 - 98.26
Volume6,882,615
Average volume (3 months)6,099,429
Market cap$153.2B
Dividend yield2.66%
Data as of 4:00pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+15.97%
Earnings growth (this year)+14.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+12.16%
P/E ratio23.6
Price/Sales3.98
Price/Book33.01

Competitors

 Today’s
change
Today’s
% change
SNYSanofi-0.51-1.02%
CELGCelgene-14.63-10.76%
GSKGlaxoSmithKline-0.26-0.63%
BMYBristol-Myers Squibb-0.25-0.39%
Data as of 4:14pm ET, 10/20/2017

Financials

Next reporting dateOctober 27, 2017
EPS forecast (this quarter)$1.38
Annual revenue (last year)$25.6B
Annual profit (last year)$5.9B
Net profit margin23.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts